Dataset from A Comparison of Symbicort® SMART (160/4.5μg) and Symbicort® Turbuhaler 160/4.5 μg, Plus Terbutaline Turbuhaler 0.4 mg as Needed, for Treatment of Asthma - a 12-month, Randomized, Double-blind, Parallel Group, Active-controlled, Multinational Phase III Study in Asthmatic Patients From 16 Years
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00009938
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of this study is to compare the efficacy of Symbicort SMART (Symbicort
Turbuhaler 160/4.5μg, one inhalation twice daily plus as needed) with Symbicort Turbuhaler
160/4.5μg, one inhalation twice daily plus terbutaline Turbuhaler 0.4 mg as needed, as asthma
therapy
创建时间：
2025-02-10
